Resultaten visas 1 - 10 / 33
resultat / per sida
Vilka publikationsuppgifter finns i tjänsten?
Publikationens namn
Upphovspersoner
Publikationskanal
År

Stability of hepatitis C virus (HCV) RNA levels among interferon-naive HIV/HCV-coinfected individuals treated with combination antiretroviral therapy

Referentgranskad
Grint, D.; Peters, L.; Reekie, J.; Soriano, V.; Kirk, O.; Knysz, B.; Suetnov, O.; Lazzarin, A.; Lede...
Hiv medicine2013

Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe

Referentgranskad
Öppen tillgång
DOI
10.1016/j.jhep.2017.10.010
Fraser, Hannah;Martin, Natasha K.;Brummer-Korvenkontio, Henrikki;Carrieri, Patrizia;Dalgard, Olav;Di...
JOURNAL OF HEPATOLOGY2018

Early quantification of HCV core antigen may help to determine the duration of therapy for chronic genotype 2 or 3 HCV infection

Referentgranskad
DOI
10.1007/s10096-011-1486-5
Alsio, A.; Jannesson, A.; Langeland, N.; Pedersen, C.; Färkkilä, Martti Antero; Buhl, M. R.; Morch, ...
European journal of clinical microbiology and infectious diseases2012

Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2

Referentgranskad
DOI
10.1111/jvh.12352
Gane, E.; Kershenobich, D.; Seguin-Devaux, C.; Kristian, P.; Aho, I.; Dalgard, O.; Shestakova, I.; N...
Journal of viral hepatitis2015

Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2

Referentgranskad
DOI
10.1111/jvh.12350
Saraswat, V.; Norris, S.; de Knegt, R. J.; Sanchez Avila, J. F.; Sonderup, M.; Zuckerman, E.; Arkkil...
Verotus2015

Anti-HCV immunoassays based on a multiepitope antigen and fluorescent lanthanide chelate reporters

Referentgranskad
DOI
10.1016/j.jviromet.2015.11.015
Teppo Salminen, Etvi Juntunen, Navin Khanna, Kim Pettersson, Sheikh M. Talha
Journal of Virological Methods2016

Prevalence of chronic HCV infection in EU/EEA countries in 2019 using multiparameter evidence synthesis

Referentgranskad
Öppen tillgång
DOI
10.1016/j.lanepe.2023.100792
Thomadakis, Christos; Gountas, Ilias; Duffell, Erika; Gountas, Konstantinos; Bluemel, Benjamin; Seyl...
LANCET REGIONAL HEALTH-EUROPE2024

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

Referentgranskad
Öppen tillgång
DOI
10.1016/S2468-1253(17)30284-4
INHSU; Marshall, Alison D.; Cunningham, Evan B.; Nielsen, Stine; Aghemo, Alessio; Alho, Hannu; Backm...
The Lancet gastroenterology & hepatology2018

A Novel Fibrosis Index Comprising a Non-Cholesterol Sterol Accurately Predicts HCV-Related Liver Cirrhosis

Referentgranskad
Öppen tillgång
DOI
10.1371/journal.pone.0093601
Ydreborg, Magdalena; Lisovskaja, Vera; Lagging, Martin; Christensen, Peer Brehm; Langeland, Nina; Bu...
PLoS ONE2014

Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis

Referentgranskad
Öppen tillgång
DOI
10.1186/s12954-021-00505-4
Shayan, Shah Jahan; Nazari, Rajab; Kiwanuka, Frank
Harm reduction journal2021

Stability of hepatitis C virus (HCV) RNA levels among interferon-naive HIV/HCV-coinfected individuals treated with combination antiretroviral therapy

Referentgranskad
2013

Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe

Referentgranskad
Öppen tillgång
DOI
10.1016/j.jhep.2017.10.010
2018

Early quantification of HCV core antigen may help to determine the duration of therapy for chronic genotype 2 or 3 HCV infection

Referentgranskad
DOI
10.1007/s10096-011-1486-5
2012

Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2

Referentgranskad
DOI
10.1111/jvh.12352
2015

Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2

Referentgranskad
DOI
10.1111/jvh.12350
2015

Anti-HCV immunoassays based on a multiepitope antigen and fluorescent lanthanide chelate reporters

Referentgranskad
DOI
10.1016/j.jviromet.2015.11.015
2016

Prevalence of chronic HCV infection in EU/EEA countries in 2019 using multiparameter evidence synthesis

Referentgranskad
Öppen tillgång
DOI
10.1016/j.lanepe.2023.100792
2024

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

Referentgranskad
Öppen tillgång
DOI
10.1016/S2468-1253(17)30284-4
2018

A Novel Fibrosis Index Comprising a Non-Cholesterol Sterol Accurately Predicts HCV-Related Liver Cirrhosis

Referentgranskad
Öppen tillgång
DOI
10.1371/journal.pone.0093601
2014

Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis

Referentgranskad
Öppen tillgång
DOI
10.1186/s12954-021-00505-4
2021